ReviewJournal of thoracic disease2024

Values of circulating tumor DNA for non-small cell lung cancer patients receiving neoadjuvant therapy, progress and challenges: a narrative review.

Sicheng Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.